Isn't it interesting that they don't claim patents! Or, at the very least, patents pending!
How will they find investors if they don't have protected IP?
Charter and Brown claim to have co-invented something. What's to stop other companies from copying their "invention?"
Regardless -- I am amused at the notion that this cstAMDL website is a "smokescreen" or a diversion. It is a better website than Radient, GCDx, or AMDL ever had. The Directors of CST do not consider that website to be a smokescreen, which means I don't either.
I notice that AMDL Australia changed their Business Name to "Cancer Screen Technologies" in Australia. That name is also a Limited Corporation in good standing in Hong Kong. The only thing missing is a patent.
Well, not the ONLY thing..... some of the other things conspicuously missing:
1. News about Radient Pharmaceuticals
2. Any reference to Radient Pharmaceuticals, Provista, GCDx, UNI, Arima, SRL, or Astellas on the cstAMDL website
3. Communication from Radient Pharmaceuticals to RXPC shareholders
4. Any rational reason to believe that existing RXPC shares will ever be profitable. There is a chance that they will trade again in 2021 after the statutes of limitation expire, but the Officers will execute a huge R/S and issue more shares, dropping those .0001 shares to .000001 split-adjusted in short order for another 99% loss. THAT would be a free-fall.
AI
